SNDL Reports Fourth Quarter and Full Year 2024 Financial and Operational Results
Canada NewsWire
CALGARY, AB, March 18, 2025
The Company reports Record Full Year Net Revenue, Gross Profit and Gross Margin, as well as positive Cash Flow and Free Cash Flow
CALGARY, AB, March 18, 2025 /CNW/ - SNDL Inc. $(SNDL)$ ("SNDL" or the "Company") reported its financial and operational results for the full year and fourth quarter ended December 31, 2024. All financial information in this press release is reported in millions of Canadian dollars unless otherwise indicated.
SNDL has also posted a supplemental investor presentation and shareholder letter on its website, found at https://sndl.com.
The Company will hold a conference call and webcast presentation at 10:00 a.m. EDT (8:00 a.m. MDT) on Tuesday, March 18, 2025. The conference call details can be found below.
MANAGEMENT HIGHLIGHTS
-- Net revenue for the fourth quarter of 2024 was $257.7 million, and $920.4
million for the full year of 2024, representing growth of +3.7% and +1.3%,
respectively, when compared to the same periods of the previous year.
Both the quarter and the full year represent new records for the
corporation, driven by strong growth from our combined Cannabis business
of +16.5% in the fourth quarter and +10.6% over the full year.
-- Gross profit also reached new records, with $68.8 million in the fourth
quarter of 2024, and $240.3 million for the full year, representing
growth of +20.0% and +26.2%, respectively, when compared to the same
periods of the previous year.
-- Gross margin (1) of 26.7% in the fourth quarter of 2024 and 26.1% for the
full year are also new records, representing improvements of +3.6 and
+5.2 percentage points, respectively, when compared to the same periods
of the previous year.
-- Operating loss was $(76.1) million for the fourth quarter of 2024, driven
by a negative valuation adjustment of the SunStream portfolio of $(65.7)
million, a Spiritleaf intangible write-off of $(15.0) million, and
restructuring charges of $(0.6) million. Excluding these exceptional
items adding up to $(81.3) million, our underlying Operating Income would
have been positive for the quarter. These exceptional items largely
contributed to the full year reported Operating loss of $(103.8) million.
-- Cash flow was negative by $(44.6) million in the fourth quarter of 2024,
driven by the acquisition of Nova's minority equity interest, as well as
the repurchase of SNDL's common shares. Full-year cash flow was positive
by $23.3 million.
-- Free cash flow (1) was positive both in the fourth quarter of 2024, at
$11.6 million, and for the full year, at $8.9 million.
"We are pleased with the continued progress reflected in our fourth-quarter and full-year 2024 results, as we set new records and exceeded our commitment to achieving break-even free cash flow for the year. We have accomplished this while continuing to transform our business by investing in growth opportunities and strengthening our organizational capabilities. The SNDL team remains dedicated to raising the bar in 2025 and beyond," said Zach George, Chief Executive Officer of SNDL.
"During the fourth quarter of 2024 and the first months of 2025 up to this date, we took several strategic steps to enhance our foundation for long-term success and shareholder value:
-- Completed the privatization of Nova Cannabis Inc. through the acquisition
of the remaining minority equity interest
-- Acquired business and assets of Indiva Inc. ("Indiva"), positioning SNDL
as the largest manufacturer of infused edibles in Canada
-- Received approval from the Florida Department of Health for the transfer
of the Parallel (Surterra Holdings, Inc.) license - an important
milestone and prerequisite for completing the Parallel restructuring
process
-- Repurchased 10,764,107 SNDL common shares for cancellation at an average
price of US$1.81 per share
-- Acquired 4,350,000 common shares of High Tide Inc. ("High Tide"),
equivalent to 5.4% ownership
In addition to these achievements, the Company has applied for listing of its common shares on the Canadian Securities Exchange ("CSE") and anticipate the CSE listing to go live in April 2025, providing our shareholders with increased flexibility and optionality.
The progress made during the last year in operational performance and financial discipline is undeniable, and we are encouraged by the many opportunities we still have ahead of us. Our strong balance sheet, including $218.4 million of unrestricted cash as of December 31, 2024, is not only a competitive differentiator but also gives us the flexibility to thoughtfully deploy capital into organic and inorganic investments with attractive returns. Our plan is to continue building strong fundamentals, as we expect to build momentum through 2025 with the goal of generating $100 million in positive annual free cash flow within the next three years.
We want to thank our employees for their dedication and passion in delivering the progress we made during the last year, as well as our shareholders for their continued trust and support," concluded Zach George.
TOTAL COMPANY HIGHLIGHTS
Three months ended December 31 Year ended December 31
($000s) 2024 2023 % Change 2024 2023 % Change
IFRS
Financial
Measures
------------
Net revenue 257,679 248,450 3.7% 920,448 909,006 1.3%
Gross profit 68,799 57,336 20.0% 240,331 190,415 26.2%
Operating
loss (76,089) (85,017) 10.5% (103,811) (163,171) 36.4%
Change in
cash and
cash
equivalents (44,617) (6,942) -543% 23,318 (84,545) 128%
Non-IFRS
Financial
Measures (1)
------------
Gross margin 26.7% 23.1% 3.6 pp 26.1% 20.9% 5.2 pp
Adjusted
operating
loss (60,472) (27,094) -123% (86,144) (98,028) 12%
Free cash
flow 11,625 1,383 741% 8,872 (60,883) 115%
(1) Gross Margin is a supplementary financial measure
calculated by dividing Gross Profit by Net Revenue.
Adjusted operating income (loss) and Free Cash Flow
are specified financial measures that do not have
a standardized meanings prescribed by IFRS and therefore
may not be comparable to similar measures reported
by other companies. See "Non-IFRS Measures" section
below for further information.
BUSINESS SEGMENT HIGHLIGHTS
SNDL's business is operated and reported in four segments: Liquor Retail, Cannabis Retail, Cannabis Operations and Investments. Corporate and Shared Service expenses, as well as the revenue elimination associated with the Cannabis Operations sales to the provincial boards that are expected to be subsequently repurchased by the Company's licensed retail subsidiaries for resale, are reported as "Corporate".
Three months ended December Year ended December 31
31
($000s) 2024 2023 % Change 2024 2023 % Change
Net Revenue
------------
Liquor Retail 154,080 159,493 -3.4% 555,259 578,895 -4.1%
Cannabis
Retail 83,170 75,152 10.7% 311,689 289,980 7.5%
Cannabis
Operations 37,092 26,044 42.4% 109,470 87,071 25.7%
Investments -- -- 0% -- -- 0%
Corporate (16,663) (12,239) -36.1% (55,970) (46,940) -19.2%
Total 257,679 248,450 3.7% 920,448 909,006 1.3%
Operating
Income
------------
Liquor Retail 12,325 10,120 21.8% 34,781 24,655 41.1%
Cannabis
Retail (8,997) (849) -959.7% (1,742) 4,840 -136.0%
Cannabis
Operations 4,391 (65,749) 106.7% 2,663 (112,744) 102.4%
Investments (63,724) (5,217) -1121.5% (50,013) 11,746 -525.8%
Corporate (20,084) (23,322) 13.9% (89,500) (91,668) 2.4%
Total (76,089) (85,017) -10.5% (103,811) (163,171) 400.2%
Adjusted
Operating
Income
------------
Liquor Retail 12,325 10,120 21.8% 34,781 24,655 41.1%
Cannabis
Retail 6,003 (849) 807.1% 13,258 4,840 173.9%
Cannabis
Operations 4,439 (7,715) 157.5% 3,091 (52,728) 105.9%
Investments (63,724) (5,217) -1121.5% (50,013) 11,746 -525.8%
Corporate (19,515) (23,433) 16.7% (87,261) (86,541) -0.8%
Total (60,472) (27,094) -1355.1% (86,144) (98,028) 133.4%
Liquor Retail
SNDL is Canada's largest private sector liquor retailer, operating at March 17, 2025 in 165 locations, predominantly in Alberta, under its three retail banners: "Wine and Beyond" (13), "Liquor Depot" (19), and "Ace Liquor" (133).
Three months ended December 31 Year ended December 31
($000s) 2024 2023 % Change 2024 2023 % Change
Net Revenue 154,080 159,493 -3.4% 555,259 578,895 -4.1%
Gross
Profit 38,236 38,396 -0.4% 139,706 137,286 1.8%
Gross
margin 24.8% 24.1% 0.7 pp 25.2% 23.7% 1.4 pp
Operating
Income 12,325 10,120 21.8% 34,781 24,655 41.1%
Adjusted
Operating
Income 12,325 10,120 21.8% 34,781 24,655 41.1%
-- Net revenue for Liquor Retail continued to decline in the fourth quarter
of 2024, although at a slightly slower pace than in previous quarters, as
we continue to experience market demand softness. Same store sales (2)
decreased by -3.5% in the fourth quarter, and -4.6% for the full year.
-- Operating Income expanded significantly in both the fourth quarter and
the full year, despite the revenue declines, driven by the introduction
early in the year of our proprietary data licensing program, enhanced
pricing and mix management strategies, including private label expansion
at accretive margins, as well as cost optimization and in-store
productivity improvements.
(2) Same store sales are specified financial measures
that do not have standardized meanings prescribed
by IFRS Accounting Standards and therefore may not
be comparable to similar measures used by other companies.
Refer to the "Non-IFRS Financial Measures and Other
Measures" section of this MD&A for further information.
Cannabis Retail
SNDL is one of Canada's largest private-sector cannabis retailer, operating at March 17, 2025 in 185 locations under its three retail banners: "Value Buds" (117), "Spiritleaf" (67, of which 8 are corporate stores and 59 are franchise stores), and "Superette" (1). The Company's Cannabis Retail strategy is based on several pillars, including the quality of its store locations, its range of products, and the unique experiences provided to customers. Using data and insights from a large volume of monthly transactions enables SNDL to leverage technology and analytics to inform and improve its retail strategy.
Three months ended December 31 Year ended December 31
($000s) 2024 2023 % Change 2024 2023 % Change
Net Revenue 83,170 75,152 10.7% 311,689 289,980 7.5%
Gross
Profit 20,490 20,045 2.2% 78,827 73,690 7.0%
Gross
margin 24.6% 26.7% -2.0 pp 25.3% 25.4% -0.1 pp
Operating
Income (8,997) (849) -959.7% (1,742) 4,840 -136.0%
Adjusted
Operating
Income 6,003 (849) 807.1% 13,258 4,840 173.9%
-- Net revenue for Cannabis Retail grew dynamically over the full year, and
particularly in the fourth quarter, as our Value Buds banner continues to
gain market share, and we also run some additional promotional activities
in the fourth quarter. Same store sales increased by +6.3% in the fourth
quarter, and +3.5% over the full year.
-- Operating Income was impacted in the fourth quarter by a $15
million Spiritleaf intangible asset impairment, as we have converted
several Spiritleaf stores into Value Buds. These conversions are
increasing revenue, profitability and cash flow, and therefore create
shareholder value. However, when the profit pool associated with the
Spiritleaf intangible asset was reduced, it triggered the one-time
non-cash impairment.
-- Adjusted Operating Income excludes the Spiritleaf intangible impairment,
showing the underlying operational profitability of the segment, which
has seen a material improvement when compared to the previous year, both
in the fourth quarter and the full year.
Cannabis Operations
SNDL has a diverse brand portfolio from value to premium, emphasizing premium inhalable formats and a full suite of 2.0 products. With enhanced procurement capabilities and plans to continue evolving toward a cost-effective cultivation and manufacturing operation, the Cannabis Operations segment is a key enabler of SNDL's vertical integration strategy.
Three months ended December 31 Year ended December 31
($000s) 2024 2023 % Change 2024 2023 % Change
Net Revenue 37,092 26,044 42.4% 109,470 87,071 25.7%
Gross
Profit 10,073 (1,105) 1011.6% 21,798 (20,561) 206.0%
Gross
margin 27.2% -4.2% 31.4 pp 19.9% -23.6% 43.5 pp
Operating
Income 4,391 (65,749) 106.7% 2,663 (112,744) 102.4%
Adjusted
Operating
Income 4,439 (7,715) 157.5% 3,091 (52,728) 105.9%
-- Cannabis Operations reported a significant step up in revenues and
profitability throughout the year, and particularly in the fourth quarter
of 2024.
-- Net revenue expansion is driven by increased provincial board and
Business-to-Business distribution and a continued focus on consumer
innovation, quality and operational efficiencies. Reported revenue
includes $7.5 million from Indiva between November 4 and December 31,
2024.
-- Gross profit and Operating Income improvements are driven by efficiency
improvements from scale as well as productivity initiatives.
Investments
-- As of December 31, 2024, the Company has deployed capital to a portfolio
of cannabis-related investments with a carrying value of $449.1 million,
including $413.1 million to SunStream Bancorp Inc. ("SunStream"). This
carrying value was reduced by $51.3 million during the fourth quarter of
2024, mainly driven by a negative valuation adjustment of the SunStream
portfolio.
-- In the fourth quarter of 2024, the investment portfolio generated
negative operating income of $(63.7) million, including a $(65.7) million
negative valuation adjustment of equity-accounted investees (SunStream
portfolio). This non-cash valuation adjustment is the consequence of
multiple factors, including increased U.S. industry risk and volatility
following the negative adult use Florida vote last November, as well as
the worsening performance of Parallel and Skymint investments due to
delays in the completion of their restructuring process while operating
in challenging competitive environments.
-- The negative Florida election vote to legalize adult use cannabis in this
state is seen as an unfavorable development by the industry and the
investor community, as evidenced by the significant declines in equity
valuation of different Cannabis multi-state-operators. For SNDL's
investment in SunStream assets, we find a positive in this development,
as it gives Parallel more time to complete its restructuring process
without the additional competitive pressure of a changing market
environment.
-- Subsequent to the end of the fourth quarter, on February 4, 2025, the
Florida Department of Health approved the transfer of Parallel's license.
While a few additional steps are still required, this is an important
milestone in completing Parallel's restructuring process.
-- On March 17, 2025 the Company announced the purchase of 4,350,000 common
shares of High Tide, equivalent to 5.4% ownership, at an average price of
US$2.46 per share.
Equity Position
-- $667.6 million of unrestricted cash, marketable securities and
investments, including investments in equity-accounted investees, and no
outstanding debt at December 31, 2024, resulting in a net book value of
$1.1 billion.
-- On November 14, 2024, the Company announced that its board of directors
had approved a renewal of the share repurchase program upon its expiry on
November 20, 2024. The Company's share repurchase program continues to be
available to lower the outstanding share float. SNDL will continue to
assess opportunities to utilize the program to the extent that management
believes it is in the best interest of SNDL's shareholders. During the
three months ending December 31, 2024, the Company repurchased 5,002,372
common shares for cancelation at an average price of US$1.84 per share.
Subsequent to the quarter end, in January and February 2025 the Company
repurchased an additional 5,761,735 common shares for cancellation at an
average price of US$1.79 per share. This brings the total number of
common shares repurchased during the last 6 months to a total of
10,764,107 at an average price of US$1.81 per share.
This press release is intended to be read in conjunction with the Company's consolidated financial statements and the notes thereto for the years ended December 31, 2024 and 2023, and the accompanying Management's Discussion and Analysis. These documents are available under the Company's profile on SEDAR+ at www.sedarplus.ca and EDGAR at www.sec.gov/edgar.shtml.
CONFERENCE CALL
The Company will hold a conference call and webcast presentation at 10:00 a.m. EDT (8:00 a.m. MDT) on Tuesday, March 18, 2025.
WEBCAST ACCESS
To access the live webcast of the call, please visit the following link:
https://edge.media-server.com/mmc/p/yxxmbsby
REPLAY
A replay of the webcast will be available at https://sndl.com/financials/quarterly-results/default.aspx
ABOUT SNDL INC.
SNDL Inc. (NASDAQ: SNDL), through its wholly owned subsidiaries, is one of the largest vertically integrated cannabis companies and the largest private-sector liquor and cannabis retailer in Canada, with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, Spiritleaf and Superette. With products available in licensed cannabis retail locations nationally, SNDL's consumer-facing cannabis brands include Top Leaf, Contraband, Palmetto, Bon Jak, La Plogue, Versus, Value Buds, Grasslands, Vacay, Pearls by Grön, No Future and Bhang Chocolate. SNDL's investment portfolio seeks to deploy strategic capital through direct and indirect investments and partnerships throughout the North American cannabis industry. For more information, please visit www.sndl.com
Forward-Looking Information Cautionary Statement
This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"), including, but not limited to, statements regarding the Company's operational goals and plans, the anticipated impact of the Company's strategic steps on long-term success and shareholder value, the Company's intentions to activate a listing on the CSE and anticipated timing thereof, the anticipated benefit of the Company's strong balance sheet, the Company's strategy with respect to its operating segments, the impact of the negative Florida election vote to legalize adult use cannabis, expectations with respect to the Parallel restructuring process, the Company's margin improvement initiatives, the Company's ability to achieve long-term, sustainable profitability, growth and efficiencies, the Company's long-term strategic plan, the benefits of the Company's Investment Segment portfolio, expectations with respect to sharing information with investors, the Company's retail strategy, expectations with respect to the Company's Cannabis Operations segment, the Company's vertical integration strategy, the Company's proprietary data licensing program, expansion of product offerings (including the expected expansion of the Company's private labels), performance of the Company's investments, including through the SunStream joint venture and SunStream USA Group, expectations with respect to the SunStream USA Group, the timing and closing of the transactions with Parallel and Skymint, potential local and international regulatory changes, the share repurchase program, including the anticipated benefits thereof, and any other potential forms of shareholder value creation. Forward-looking statements are frequently characterized by words such as "aim", "anticipate", "assume", "believe", "contemplate", "continue", "could", "due", "estimate", "expect", "goal", "intend", "may", "objective", "plan", "predict", "potential", "positioned", "pioneer", "seek", "should", "target", "will", "would", and other similar expressions that are predictions of or indicate future events and future trends, or the negative of these terms or other comparable terminology. These forward-looking statements are based on current expectations, estimates, forecasts and projections about the Company's business and the industry in which it operates and management's beliefs and assumptions and are not guarantees of future performance or development and involve known and unknown risks, uncertainties and other factors that are in some cases beyond its control. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. Please see "Risk Factors" in the Company's Annual Information Form dated March 18, 2025, and the risk factors included in our other public disclosure documents for a discussion of the material risk factors that could cause actual results to differ materially from the forward-looking information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Condensed Consolidated Statement of Loss and Comprehensive Loss
(Expressed in thousands of Canadian dollars, except per share amounts)
Year endedDecember 31
2024 2023
Net revenue 920,448 909,006
Cost of sales 680,117 718,591
Gross profit 240,331 190,415
Investment income 15,551 5,259
Share of (loss) profit of
equity-accounted investees (65,459) 6,758
General and administrative 187,243 199,725
Sales and marketing 12,004 15,045
Research and development 346 324
Depreciation and amortization 54,250 60,216
Share-based compensation 20,037 15,400
Restructuring costs 2,667 19,573
Asset impairment, net 17,317 54,967
Loss on disposition of assets 370 353
Operating loss (103,811) (163,171)
Other expenses, net (1,798) (8,845)
Loss before income tax (105,609) (172,016)
Income tax recovery 9,405 --
Net loss from continuing operations (96,204) (172,016)
Net loss from discontinued operations -- (4,535)
Net loss (96,204) (176,551)
Equity-accounted investees - share of
other comprehensive
income (loss) 31,489 (12,771)
Investments at FVOCI - change in fair 1,864 --
value
Comprehensive loss (62,851) (189,322)
Net loss from continuing operations
attributable to:
Owners of the Company (94,796) (168,125)
Non-controlling interest (1,408) (3,891)
(96,204) (172,016)
Net loss attributable to:
Owners of the Company (94,796) (172,660)
Non-controlling interest (1,408) (3,891)
(96,204) (176,551)
Comprehensive loss attributable to:
Owners of the Company (61,443) (185,431)
Non-controlling interest (1,408) (3,891)
Condensed Consolidated Statement of Financial Position
(Expressed in thousands of Canadian dollars)
As at December 31, 2024 December 31, 2023
Assets
Current assets
Cash and cash equivalents 218,359 195,041
Restricted cash 19,815 19,891
Marketable securities 139 225
Accounts receivable 28,118 27,059
Biological assets 1,187 429
Inventory 127,919 129,060
Prepaid expenses and deposits 16,860 22,464
Investments 27,560 3,400
Assets held for sale 19,051 6,375
Net investment in subleases 2,832 2,970
461,840 406,914
Non-current assets
Long-term deposits and
receivables 3,679 4,837
Right of use assets 115,435 129,679
Property, plant and equipment 145,810 152,916
Net investment in subleases 15,354 18,396
Intangible assets 61,325 73,149
Investments 8,427 29,660
Equity-accounted investees 413,124 538,331
Goodwill 124,248 119,282
Total assets 1,349,242 1,473,164
Liabilities
Current liabilities
Accounts payable and accrued
liabilities 56,275 68,210
Lease liabilities 34,256 30,537
Derivative warrants 26 4,400
90,557 103,147
Non-current liabilities
Lease liabilities 118,017 136,492
Other liabilities 7,312 4,185
Total liabilities 215,886 243,824
Shareholders' equity
Share capital 2,346,728 2,375,950
Warrants 667 2,260
Contributed surplus 57,156 73,014
Contingent consideration -- 2,279
Accumulated deficit (1,323,965) (1,260,851)
Accumulated other comprehensive
income 52,770 19,417
Total shareholders' equity 1,133,356 1,212,069
Non-controlling interest -- 17,271
Total liabilities and
shareholders' equity 1,349,242 1,473,164
Condensed Consolidated Statement of Cash Flows
(Expressed in thousands of Canadian dollars)
Year endedDecember 31
2024 2023
Cash provided by (used in):
Operating activities
Net loss for the period (96,204) (176,551)
Adjustments for:
Income tax recovery (9,405) --
Interest and fee income (15,637) (14,517)
Change in fair value of biological assets (892) 7,936
Share-based compensation 20,037 15,400
Depreciation and amortization 56,711 64,946
Loss on disposition of assets 370 353
Inventory impairment and obsolescence 3,707 30,644
Finance costs, net 7,161 11,362
Change in estimate of fair value of
derivative warrants (4,374) (6,602)
Unrealized foreign exchange loss 108 (13)
Transaction costs 164 1,221
Bargain purchase gain (5,456) --
Asset impairment, net 17,317 54,967
Share of loss (profit) of
equity-accounted investees 65,459 (6,758)
Realized loss on settlement of marketable
securities -- 138,874
Unrealized loss (gain) on marketable
securities 86 (129,616)
Proceeds from settlement of marketable
securities -- 6,704
Income distributions from 10,715 --
equity-accounted investees
Interest received 12,494 13,563
Change in non-cash working capital (7,447) (32,875)
Net cash provided by (used in) operating
activities
from continuing operations 54,914 (20,962)
Net cash provided by operating activities
from discontinued
operations -- 4,314
Net cash provided by (used in) operating
activities 54,914 (16,648)
Investing activities
Additions to property, plant and
equipment (8,615) (7,845)
Additions to intangible assets (2,404) (87)
Changes to investments (22,617) (732)
Capital refunds (contributions) to
equity-accounted
investees 168 (25,089)
Capital distributions from 89,758 --
equity-accounted investees
Proceeds from disposal of property, plant
and equipment 734 1,213
Acquisitions, net of cash acquired (39,644) 3,695
Change in non-cash working capital 383 4,028
Net cash provided by (used in) investing
activities 17,763 (24,817)
Financing activities
Change in restricted cash 76 (553)
Payments on lease liabilities, net (36,952) (41,013)
Repurchase of common shares (13,219) (1,536)
Proceeds from issuance of shares, net (59) --
of costs
Issuance of common shares by 174 --
subsidiaries
Distributions declared by subsidiaries -- (20)
Change in non-cash working capital 621 42
Net cash used in financing activities (49,359) (43,080)
Change in cash and cash equivalents 23,318 (84,545)
Cash and cash equivalents, beginning of
period 195,041 279,586
Cash and cash equivalents, end of period 218,359 195,041
NON-IFRS MEASURES
Certain specified financial measures in this news release are non-IFRS measures. These terms are not defined by IFRS and, therefore, may not be comparable to similar measures reported by other companies. These non-IFRS financial measures should not be considered in isolation or as an alternative for or superior to measures of performance prepared in accordance with IFRS. These measures are presented and described in order to provide shareholders and potential investors with additional measures in understanding the Company's operating results in the same manner as the management team.
ADJUSTED OPERATING INCOME (LOSS)
Adjusted operating income (loss) is a non-IFRS financial measure which the Company uses to evaluate its operating performance in a similar manner to its management team. The Company defines adjusted operating income (loss) as operating income (loss) less restructuring costs (recovery), goodwill and intangible asset impairments and asset impairments triggered by restructuring activities.
The following tables reconcile adjusted to un-adjusted operating income (loss) for the periods noted.
($000s) LiquorRetail CannabisRetail CannabisOperations Investments Corporate Total Three months ended December 31, 2024 Operating income (loss) 12,325 (8,997) 4,391 (63,724) (20,084) (76,089) Adjustments: Restructuring costs -- -- 48 -- 569 617 Goodwill and intangible asset impairments -- 15,000 -- -- -- 15,000 Adjusted operating income (loss) 12,325 6,003 4,439 (63,724) (19,515) (60,472) ($000s) LiquorRetail CannabisRetail CannabisOperations Investments Corporate Total Three months ended December 31, 2023 Operating income (loss) 10,120 (849) (65,749) (5,217) (23,322) (85,017) Adjustments: Restructuring costs (recovery) -- -- 13,398 -- (111) 13,287 Goodwill and intangible asset impairments -- -- 29,000 -- -- 29,000 Impairments triggered by restructuring -- -- 15,636 -- -- 15,636 Adjusted operating income (loss) 10,120 (849) (7,715) (5,217) (23,433) (27,094) ($000s) LiquorRetail CannabisRetail CannabisOperations Investments Corporate Total Year ended December 31, 2024 Operating income (loss) 34,781 (1,742) 2,663 (50,013) (89,500) (103,811) Adjustments: Restructuring costs -- -- 428 -- 2,239 2,667 Goodwill and intangible asset impairments -- 15,000 -- -- -- 15,000 Adjusted operating income (loss) 34,781 13,258 3,091 (50,013) (87,261) (86,144) ($000s) LiquorRetail CannabisRetail CannabisOperations Investments Corporate Total Year ended December 31, 2023 Operating income (loss) 24,655 4,840 (112,744) 11,746 (91,668) (163,171) Adjustments: Restructuring costs -- -- 14,446 -- 5,127 19,573 Goodwill and intangible asset impairments -- -- 29,934 -- -- 29,934 Impairments triggered by restructuring -- -- 15,636 -- -- 15,636 Adjusted operating income (loss) 24,655 4,840 (52,728) 11,746 (86,541) (98,028)
GROSS MARGIN
Gross margin is a supplementary financial measure calculated by dividing gross profit by net revenue for the periods noted.
FREE CASH FLOW
Free cash flow is a non-IFRS financial measure which the Company uses to evaluate its financial performance, providing information which management believes to be useful in understanding and evaluating the Company's ability to generate positive cash flows as it removes cash used for non-operational items. The Company defines free cash flow as the total change in cash and cash equivalents less cash used for common share repurchases, dividends (if any), changes to debt instruments, changes to long-term investments, net cash used for acquisitions plus cash provided by dispositions (if any).
The following table reconciles free cash flow to change in cash and cash equivalents for the periods noted.
Three months Year endedDecember
endedDecember 31 31
($000s) 2024 2023 2024 2023
Change in cash
and cash
equivalents (44,617) (6,942) 23,318 (84,545)
Adjustments
Repurchase of
common shares 13,219 -- 13,219 1,536
Changes to
long-term
investments 5,033 8,325 (67,309) 25,821
Acquisitions,
net of cash
acquired 37,990 -- 39,644 (3,695)
Free cash flow 11,625 1,383 8,872 (60,883)
SAME STORE SALES
Same store sales is a non-IFRS financial measure which the Company uses to evaluate its financial performance in its retail segments. Same store sales provides information which management believes to be useful to investors, analysts and others in understanding and evaluating the Company's sales trends excluding the effect of the opening and closure of stores.
Same store sales refers to the revenue generated by the Company's existing retail locations during the current and prior comparison periods.
View original content to download multimedia:https://www.prnewswire.com/news-releases/sndl-reports-fourth-quarter-and-full-year-2024-financial-and-operational-results-302403826.html
SOURCE SNDL Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/March2025/18/c5467.html
/CONTACT:
For more information: Tomas Bottger, SNDL Inc., O: 1.587.327.2017, E: investors@sndl.com
Copyright CNW Group 2025
(END) Dow Jones Newswires
March 18, 2025 07:00 ET (11:00 GMT)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.